Location History:
- Lahore, PK (2012)
- Karachi, PK (2014 - 2019)
Company Filing History:
8 out of 832,912 Years Active: 2012-2019
Title: Khalid Mohammed Khan: Innovator in Diabetes Treatment and Organic Synthesis
Introduction
Khalid Mohammed Khan is a prominent inventor based in Karachi, Pakistan. He has made significant contributions to the fields of diabetes treatment and organic synthesis. With a total of 8 patents to his name, Khan is recognized for his innovative approaches to complex scientific challenges.
Latest Patents
One of his latest patents is titled "2, 4-dinitroanilino-benzoic acid: novel insulinotropic agent for the treatment of diabetes." This study established that the treatment of diabetes using compound 1 (2,4-dinitroanilino-benzoic acid), an anthranilic acid derivative, restores the functional activities of the pancreas via its insulinotropic action. Another notable patent is the "Process for the preparation of quinoline based ionic fluoride salts (QUFS)." This invention relates to ionic liquid preparation and their application in organic synthesis, specifically focusing on quinoline-based ionic liquids with fluoride counter anions and their applications in click chemistry and Knoevenagel condensation.
Career Highlights
Khalid Mohammed Khan has dedicated his career to advancing scientific knowledge and practical applications in his fields of expertise. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Khan has collaborated with esteemed colleagues such as Atta-Ur Rahman and Muhammad Iqbal Choudhary, further enhancing the impact of his research and inventions.
Conclusion
Khalid Mohammed Khan is a distinguished inventor whose work in diabetes treatment and organic synthesis continues to influence the scientific landscape. His contributions are a testament to the power of innovation in addressing critical health challenges.